Crossmark

Glycemic outcomes of Advanced Hybrid Closed Loop system in children and adolescents with Type 1 Diabetes, previously treated with Multiple Daily Injections (MiniMed 780G system in T1D individuals, previously treated with MDI)

Crossref DOI link: https://doi.org/10.1186/s12902-022-00996-7

Published Online: 2022-03-29

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Petrovski, Goran https://orcid.org/0000-0002-8622-2186
Al Khalaf, Fawziya

Campbell, Judith

Day, Emma

Almajaly, Douha

Hussain, Khalid

Pasha, Maheen

Umer, Fareeda

Hamdan, Manar

Khalifa, Amel
License Information

Text and Data Mining valid from 2022-03-29

Version of Record valid from 2022-03-29
More Information

Article History

Received: 28 November 2021

Accepted: 14 March 2022

First Online: 29 March 2022

Declarations

:

: The study was approved by the institutional review board at Sidra Medicine in Doha and national ethics committee at Ministry of public health in Qatar. All the participants, and their guardians signed a written informed assent/consent before the start of study-related procedures.. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2005.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below